<DOC>
	<DOCNO>NCT02099838</DOCNO>
	<brief_summary>Secondary failure sulfonylurea ( SUs ) occur 30 % -40 % type 2 diabetic patient treatment SUs 5 year , although SUs widely use type 2 diabetic patient . This study design evaluate effectiveness safety add compound preparation pioglitazone metformin type 2 diabetic patient bad glycemic control initial treatment SUs .</brief_summary>
	<brief_title>Effectiveness Safety Adding Compound Preparation Pioglitazone Metformin Type 2 Diabetic Patients</brief_title>
	<detailed_description>Design clinical trial multicenter , randomize , double-blind placebo parallel control . Type 2 diabetic patient bad glycemic control initial treatment SUs include . They randomly divide experiment group control group , respectively take compound preparation pioglitazone metformin ( 2mg/500mg ) placebo identical shape immediately meal twice day . Course treatment 12 week .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetic patient ( WHO criterion , 1999 ) 19kg/m2 ≤ BMI ≤ 35kg/m2 Subject initial treatment SUs basis control diet sport ; treatment last less 3 month stable dose least 1 month ; HbA1c 711 % No insulin therapy 6 month select Not involved drug test 3 month select No serious heart , liver kidney disease Must effective contraception method woman childbearing age Willing inform consent Type 1 diabetes specific type diabetes Pregnancy , preparation pregnancy , lactation woman childbearing age incapable effective contraception method Uncooperative subject various reason Abnormal liver function , glutamicpyruvic transaminase ( ALT ) glutamicoxaloacetic transaminase ( AST ) ＞ twice upper limit normal Impairment renal function , serum creatinine : ≥ 133mmol/L female，≥ 135mmol/L male Serious chronic gastrointestinal disease Edema Serious heart disease , cardiac insufficiency ( level III accord NYHA ) , acute coronary syndrome old myocardial infraction Blood pressure : Systolic blood pressure ( SBP ) ≥ 180mmHg and/or diastolic blood pressure ( DBP ) ≥ 110mmHg White blood count ( WBC ) ＜ 4.0×109/L platelet count ( PLT ) ＜ 90×109/L，or definite anemia ( Hb：＜ 120g/L male , ＜ 110g/L female ) , hematological disease Endocrine system disease , hyperthyroidism hypercortisolism Experimental drug allergy frequent hypoglycemia Psychiatric disorder , drug substance abuse Diabetic ketoacidosis hyperosmolar nonketotic coma require insulin therapy Stressful situation surgery , serious trauma Chronic hypoxic disease pulmonary emphysema pulmonary heart disease Combined use drug effect glucose metabolism glucocorticoid Tumor , especially bladder tumor and/or family history bladder tumor and/or longterm hematuria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Pioglitazone</keyword>
	<keyword>Metformin</keyword>
	<keyword>Type 2 Diabetes Mellitus</keyword>
</DOC>